Description
The CSL Behring CSL300_2301 Phase 3 App is intended for use to collect patient reported outcomes relating to the CSL300_2301 Phase 3 clinical trial. Patients must be given accounts by a participating site in order to log in to the app
What's New in Version 2.15.4 (13)
Language Batch 3